EL
15
-3
DE
42
3
XOM
42
-6
WM
74
-5
MCO
71
-7
STX
45
-4
ADM
28
3
LRCX
37
-9
PGR
59
-3
YUM
43
-6
NSC
53
-4
FOX
51
-6
AMT
37
3
HIG
66
2
EXC
54
3
HSY
31
-6
IBM
47
-3
APH
65
-3
MAS
52
-4
T
48
3
EL
15
-3
DE
42
3
XOM
42
-6
WM
74
-5
MCO
71
-7
STX
45
-4
ADM
28
3
LRCX
37
-9
PGR
59
-3
YUM
43
-6
NSC
53
-4
FOX
51
-6
AMT
37
3
HIG
66
2
EXC
54
3
HSY
31
-6
IBM
47
-3
APH
65
-3
MAS
52
-4
T
48
3
Financhill
Back

Target Global Acquisition I Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
68

TGAA
Target Global Acquisition I

Last Price:
11.33
Seasonality Move:
1.58%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.51
Seasonality Move:
17.03%
Buy
68
Target Global Acquisition I (TGAA) is a Buy

Is Target Global Acquisition I a Buy, Sell or Hold?

  • The current Target Global Acquisition I [TGAA] share price is $11.33. The Score for TGAA is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • TGAA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TGAA Stock Price Chart

What is Target Global Acquisition I's stock price today?

  • The Target Global Acquisition I share price today is $11.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGAA is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

TGAA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 88.51 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.24 - 11.3) Buy
Bollinger Bands (100): (11.22 - 11.36) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

TGAA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.3 Buy
20-day SMA: 11.28 Buy
50-day SMA: 11.26 Buy
200-day SMA: 11.25 Buy
8-day EMA: 11.31 Buy
20-day EMA: 11.28 Buy
50-day EMA: 11.27 Buy
200-day EMA: 11.21 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Target Global Acquisition I Earnings Growth & TGAA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Target Global Acquisition I Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):